Reply to Martin et al.: Change in Lung Function after Initiation of Elexacaftor–Tezacaftor–Ivacaftor: Do Not Forget Anatomy!

por Nichols, David P., Rowe, Steven M.
Publicado 2022

Therapeutic Effects of α1-Antitrypsin on Psedumonas aeruginosa Infection in ENaC Transgenic Mice

por Nichols, David P., Jiang, Di, Happoldt, Carrie, Berman, Reena, Chu, Hong Wei
Publicado 2015

Potential of anti-inflammatory treatment for cystic fibrosis lung disease

por Taylor-Cousar, Jennifer L, Von Kessel, Kelsey A, Young, Robert, Nichols, David P
Publicado 2010

SERCA2 Regulates Non-CF and CF Airway Epithelial Cell Response to Ozone

por Ahmad, Shama, Nichols, David P., Strand, Matthew, Rancourt, Raymond C., Randell, Scott H., White, Carl W., Ahmad, Aftab
Publicado 2011

Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mut...

por Pohl, Kerstin, Nichols, David P., Taylor-Cousar, Jennifer L., Saavedra, Milene T., Strand, Matthew J., Nick, Jerry A., Bratcher, Preston E.
Publicado 2018

Mycobacterium abscessus Morphotype Comparison in a Murine Model

por Caverly, Lindsay J., Caceres, Silvia M., Fratelli, Cori, Happoldt, Carrie, Kidwell, Kelley M., Malcolm, Kenneth C., Nick, Jerry A., Nichols, David P.
Publicado 2015

The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network

por Pearson, Kelsie, Mayer-Hamblett, Nicole, Goss, Christopher H., Retsch-Bogart, George Z., VanDalfsen, Jill M., Burks, Patricia, Rosenbluth, Daniel, Clancy, John Paul, Hoffman, Amy, Nichols, David P.
Publicado 2021

Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR

por Young, Robert L., Malcolm, Kenneth C., Kret, Jennifer E., Caceres, Silvia M., Poch, Katie R., Nichols, David P., Taylor-Cousar, Jennifer L., Saavedra, Milene T., Randell, Scott H., Vasil, Michael L., Burns, Jane L., Moskowitz, Samuel M., Nick, Jerry A.
Publicado 2011

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

por Nichols, David P., Morgan, Sarah J., Skalland, Michelle, Vo, Anh T., Van Dalfsen, Jill M., Singh, Sachinkumar B.P., Ni, Wendy, Hoffman, Lucas R., McGeer, Kailee, Heltshe, Sonya L., Clancy, John P., Rowe, Steven M., Jorth, Peter, Singh, Pradeep K.
Publicado 2023

Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis

por Sermet-Gaudelus, Isabelle, Clancy, John P., Nichols, David P., Nick, Jerry A., De Boeck, Kris, Solomon, George M., Mall, Marcus A., Bolognese, James, Bouisset, Florilene, den Hollander, Wilhelmina, Paquette-Lamontagne, Nicolas, Tomkinson, Nigel, Henig, Noreen, Elborn, J. Stuart, Rowe, Steven M.
Publicado 2018

Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial

por Caceres, Silvia M., Sanders, Linda A., Rysavy, Noel M., Poch, Katie R., Jones, Caroline R., Pickard, Kyle, Fingerlin, Tasha E., Marcus, Roland A., Malcolm, Kenneth C., Taylor-Cousar, Jennifer L., Nichols, David P., Nick, Jerry A., Strand, Matthew, Saavedra, Milene T.
Publicado 2022

Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival

por Malcolm, Kenneth C., Nichols, E. Michelle, Caceres, Silvia M., Kret, Jennifer E., Martiniano, Stacey L., Sagel, Scott D., Chan, Edward D., Caverly, Lindsay, Solomon, George M., Reynolds, Paul, Bratton, Donna L., Taylor-Cousar, Jennifer L., Nichols, David P., Saavedra, Milene T., Nick, Jerry A.
Publicado 2013

Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design

por Mayer-Hamblett, Nicole, Nichols, David P., Odem-Davis, Katherine, Riekert, Kristin A., Sawicki, Greg S., Donaldson, Scott H., Ratjen, Felix, Konstan, Michael W., Simon, Noah, Rosenbluth, Daniel B., Retsch-Bogart, George, Clancy, John P., VanDalfsen, Jill M., Buckingham, Rachael, Gifford, Alex H.
Publicado 2021

Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome

por Nick, Jerry A., Caceres, Silvia M., Kret, Jennifer E., Poch, Katie R., Strand, Matthew, Faino, Anna V., Nichols, David P., Saavedra, Milene T., Taylor-Cousar, Jennifer L., Geraci, Mark W., Burnham, Ellen L., Fessler, Michael B., Suratt, Benjamin T., Abraham, Edward, Moss, Marc, Malcolm, Kenneth C.
Publicado 2016

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial

por Nichols, David P, Singh, Pradeep K, Baines, Arthur, Caverly, Lindsay J, Chmiel, James F, GIbson, Ronald L, Lascano, Jorge, Morgan, Sarah J, Retsch-Bogart, George, Saiman, Lisa, Sadeghi, Hossein, Billings, Joanne L, Heltshe, Sonya L, Kirby, Shannon, Kong, Ada, Nick, Jerry A, Mayer-Hamblett, Nicole
Publicado 2022

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

por Nichols, David P., Paynter, Alex C., Heltshe, Sonya L., Donaldson, Scott H., Frederick, Carla A., Freedman, Steven D., Gelfond, Daniel, Hoffman, Lucas R., Kelly, Andrea, Narkewicz, Michael R., Pittman, Jessica E., Ratjen, Felix, Rosenfeld, Margaret, Sagel, Scott D., Schwarzenberg, Sarah Jane, Singh, Pradeep K., Solomon, George M., Stalvey, Michael S., Clancy, John P., Kirby, Shannon, Van Dalfsen, Jill M., Kloster, Margaret H., Rowe, Steven M.
Publicado 2021